GSK3B and Parkinson disease: Inhibition of GSK-3β provides protection from the damaging effects of oxidative stress on dopaminergic neurons, this suggests that GSK-3β is involved in PD pathogenesis as α-synuclein is produced during phosphorylation of GSK-3β (Ni et al., 2015).